NDASUBCUTANEOUSPOWDERPriority Review
Approved
Jan 2026
Lifecycle
Launch
Competitive Pressure
18/100
Clinical Trials
1
Clinical Trials (1)
Copper Histidinate Treatment for Menkes Disease
Menkes Disease
Loss of Exclusivity
LOE Date
Jan 12, 2031
59 months away
Exclusivity Expiry
Jan 12, 2031